Ethical concern.
Doganci
Levent
L
D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016265:Conflict of Interest; D004341:Drug Evaluation / Q000941:ethics; D015340:Epidemiologic Research Design; D006479:Hemorrhagic Fever, Crimean / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D014421:Turkey / Q000453:epidemiology
D000998:Antiviral Agents; D012254:Ribavirin